iOnctura bolsters leadership team with new appointments
Steven Sciuto joins as Chief Financial Officer (CFO) bringing a wealth of experience in scaling finance functions as well as in private and public financings
Michelle Tsai PharmD, with deep expertise in portfolio strategy and lifecycle planning, joins as Chief Operating Officer (COO)
Geneva, Switzerland and Amsterdam, The Netherlands, 2 June 2025 – iOnctura, a clinical-stage biopharmaceutical company combating neglected and hard-to-treat cancers, today announces the appointments of Steven Sciuto as Chief Financial Officer (CFO) and Michelle Tsai PharmD as Chief Operating Officer (COO).
